|
AAPL
|
Technology |
DA Davidson |
Maintains
|
Buy
→
Buy
|
—
|
$4.5T
|
$42.74
|
-1.1%
|
-3.2%
|
-0.9%
|
+1.3%
|
-3.1%
|
-2.5%
|
|
TSLA
|
Consumer Cyclical |
Wedbush |
Maintains
|
Outperform
→
Outperform
|
—
|
$1.4T
|
$25.12
|
-0.5%
|
-2.9%
|
-4.7%
|
-3.3%
|
-1.2%
|
-5.3%
|
|
COST
|
Consumer Defensive |
Wells Fargo |
Maintains
|
Market Perform
→
Market Perform
|
—
|
$486.8B
|
$226.51
|
-3.8%
|
-8.6%
|
-2.3%
|
+0.4%
|
-0.8%
|
-2.1%
|
|
CSCO
|
Technology |
Nomura |
Downgrade
|
Buy
→
Neutral
|
—
|
$461.3B
|
$47.47
|
-2.3%
|
-3.5%
|
-3.5%
|
-0.3%
|
-2.1%
|
-1.5%
|
|
PG
|
Consumer Defensive |
Morgan StanleyB |
Upgrade
|
Equal Weight
→
Overweight
|
—
|
$346.8B
|
$96.49
|
-0.0%
|
+0.2%
|
-4.0%
|
-0.3%
|
-0.8%
|
-0.8%
|
|
AXP
|
Financial Services |
Barclays |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$215.6B
|
$106.70
|
-0.9%
|
-0.9%
|
-4.3%
|
-0.2%
|
-2.2%
|
-3.0%
|
|
NVO
|
Healthcare |
Morgan Stanley |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$197.0B
|
$23.39
|
-0.8%
|
-0.6%
|
-0.6%
|
-1.9%
|
-1.0%
|
+1.1%
|
|
SBUX
|
Consumer Cyclical |
Wells Fargo |
Maintains
|
Outperform
→
Outperform
|
—
|
$121.3B
|
$66.91
|
-3.7%
|
-2.3%
|
-1.3%
|
+0.7%
|
-1.3%
|
-3.0%
|
|
ADBE
|
Technology |
KeyBanc |
Maintains
|
Overweight
→
Overweight
|
—
|
$108.2B
|
$248.08
|
-3.0%
|
-7.3%
|
-3.7%
|
+2.2%
|
-0.7%
|
-2.7%
|
|
ADBE
|
Technology |
KeyBanc Capital Markets |
Maintains
|
Overweight
→
Overweight
|
—
|
$108.2B
|
$248.08
|
-3.0%
|
-7.3%
|
-3.7%
|
+2.2%
|
-0.7%
|
-2.7%
|
|
ADBE
|
Technology |
BMO Capital |
Maintains
|
Outperform
→
Outperform
|
—
|
$108.2B
|
$248.08
|
-3.0%
|
-7.3%
|
-3.7%
|
+2.2%
|
-0.7%
|
-2.7%
|
|
ADBE
|
Technology |
Morgan Stanley |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$108.2B
|
$248.08
|
-3.0%
|
-7.3%
|
-3.7%
|
+2.2%
|
-0.7%
|
-2.7%
|
|
EQNR
|
Energy |
Goldman Sachs |
Maintains
|
Sell
→
Sell
|
—
|
$106.1B
|
$22.97
|
-1.8%
|
-3.8%
|
-0.8%
|
-3.1%
|
+0.7%
|
-1.9%
|
|
GSK
|
Healthcare |
SunTrust Robinson Humphrey |
Maintains
|
Hold
→
Hold
|
—
|
$105.1B
|
$37.94
|
-0.9%
|
-0.9%
|
-1.4%
|
+0.1%
|
+0.8%
|
+1.3%
|
|
GSK
|
Healthcare |
Morgan Stanley |
Maintains
|
Underweight
→
Underweight
|
—
|
$105.1B
|
$37.94
|
-0.9%
|
-0.9%
|
-1.4%
|
+0.1%
|
+0.8%
|
+1.3%
|
|
CIEN
|
Technology |
Nomura |
Maintains
|
Buy
→
Buy
|
—
|
$78.7B
|
$34.91
|
-1.3%
|
-1.0%
|
-4.5%
|
+0.5%
|
-0.5%
|
-0.4%
|
|
CIEN
|
Technology |
BMO Capital |
Maintains
|
Outperform
→
Outperform
|
—
|
$78.7B
|
$34.91
|
-1.3%
|
-1.0%
|
-4.5%
|
+0.5%
|
-0.5%
|
-0.4%
|
|
CIEN
|
Technology |
Raymond James |
Maintains
|
Outperform
→
Outperform
|
—
|
$78.7B
|
$34.91
|
-1.3%
|
-1.0%
|
-4.5%
|
+0.5%
|
-0.5%
|
-0.4%
|
|
CIEN
|
Technology |
MKM Partners |
Maintains
|
Buy
→
Buy
|
—
|
$78.7B
|
$34.91
|
-1.3%
|
-1.0%
|
-4.5%
|
+0.5%
|
-0.5%
|
-0.4%
|
|
ORLY
|
Consumer Cyclical |
Raymond James |
Downgrade
|
Strong Buy
→
Buy
|
—
|
$78.7B
|
$23.64
|
-0.5%
|
-1.8%
|
-2.1%
|
+0.9%
|
-1.1%
|
-2.2%
|